Therapeutic area · Pulmonary arterial hypertensionUpdated October 19, 2026

EDC for pulmonary hypertension clinical trials

PAH trials hinge on a walk test, a functional class and a time-to-event, all in a small, expert population spread across few specialist centres. Capture holds the exercise test, the haemodynamics and the clinical-worsening log in one study. Build free in the sandbox, no credit card.

  • 6MWD with Borg dyspnoea
  • WHO functional class
  • Clinical worsening log

Free sandbox · No credit card · 21 CFR Part 11 aligned

6-minute walk test (demo study)
Participant 011-0006 · Week 24Draft

Exercise capacity

Distance walked

SIXMWD
421m

Change from baseline

CHG6MWD

Derived, read-only

+38 m Calculated

Borg dyspnoea, end of test

BORG
0246810

Resting SpO₂

SPO2
94%

WHO functional class

WHOFC
IIIIIIIV
Demo data only.Save
Record who supervised the test and the time of day; tests repeated at the same hour are easier to compare.

What a PAH trial needs from its EDC

  • A walk test recorded as a procedure: distance, supportive oxygen, Borg dyspnoea, heart rate and the tester, not just a number in a comment box.
  • Functional class and clinical worsening as structured data: WHO functional class at each visit and a repeating log of worsening events (death, hospitalisation, loss of exercise capacity), each with dates.
  • Haemodynamics at baseline and sometimes follow-up: right heart catheterisation results such as mean pulmonary artery pressure, wedge pressure and cardiac output with calculated vascular resistance per your protocol.
  • Biomarkers on a schedule: NT-proBNP with local or central laboratory units and ranges.
  • Small-population discipline: with a rare disease and few centres, one missing walk test is a bigger loss, so completeness reports and visit windows earn their keep.

The study data

What PAH trials measure, and how the endpoint set is built

Pulmonary arterial hypertension trials have historically been anchored on exercise capacity. The 6-minute walk distance at a fixed week is the classic primary endpoint in short placebo-controlled studies; for example, the STELLAR phase 3 trial of sotatercept used the change in 6-minute walk distance at week 24 as its primary endpoint in adults with WHO functional class II or III disease on stable background therapy, with time to clinical worsening, WHO functional class and NT-proBNP among the secondary measures (ClinicalTrials.gov NCT04576988). Longer event-driven studies shift to a composite of clinical worsening: death, hospitalisation for PAH, or deterioration in exercise capacity or functional class. Your protocol defines the exact components, and the more of them live as structured fields, the less there is to reconstruct before database lock.

The walk test is deceptively fiddly. Distance depends on corridor length, encouragement scripts, supplemental oxygen and time of day, and an unsupervised repeat can look like a treatment effect. In Capture the test is a site eCRF form with typed fields for distance, oxygen flow, Borg dyspnoea, heart rate and tester, plus a calculated change from baseline. The 6-minute walk test template shows a starting layout. A range edit check can flag distances outside a plausible band or a missing Borg score, and each correction is recorded with the old value, new value and reason.

Right heart catheterisation is required for diagnosis and often at baseline, and sometimes again at follow-up. Treat it as its own form: mean pulmonary artery pressure, pulmonary artery wedge pressure, cardiac output and index, and the vascular resistance derived from them in Wood units, with the unit and the cardiac output method recorded. Capture supports calculated fields, and a resistance formula can be built as one; confirm the exact formula and inputs with your cardiologist before you rely on it, since Capture ships specific standard derived fields (such as MAP and BMI) and expects others to be defined by the study team.

Clinical worsening as a repeating log

A time-to-event endpoint needs an onset date for every event and a clear first-event rule. Build the log with repeating rows, one per event, with type (death, PAH hospitalisation, decline in walk distance, functional class worsening, escalation of therapy), date, and the supporting visit. Repeating rows each carry their own audit trail. The adverse event template separates safety events from efficacy events so the same hospitalisation is not counted twice by accident. If a committee adjudicates events, give it a clean export; the committee process is outside Capture.

PAH study completeness view (demo data)

Week 24 walk tests entered

31 of 36

Open queries

4

Worsening events logged

5

Site 0119/10

walk tests complete

Site 0147/10

walk tests complete

Site 0196/8

walk tests complete

Demo data. A by-site view shows which centre has a missing test while the window is still open.

Protocol to build

PAH protocol elements and how they map to Capture

Protocol elementWhat the data looks likeWhere it lives in Capture
Diagnosis and eligibilityHaemodynamic criteria, group classification, functional class, background therapyEligibility screening template with range checks
Exercise capacityDistance, oxygen, Borg score, tester6-minute walk template with change from baseline
Functional classWHO class I to IV at each visit, raterSingle-choice site form field
HaemodynamicsmPAP, PAWP, cardiac output, derived resistanceDedicated form with a study-defined calculated field
Biomarkers and safety labsNT-proBNP, liver tests, haemoglobinLaboratory template
VitalsBP, heart rate, SpO₂, weightVital signs template
Clinical worseningType, date, hospital stay, sourceRepeating event log
Quality of lifeDisease-specific or generic measuresEQ-5D layout; licences stay with your study documents

Capture does not connect to echo, catheter lab or walk-test devices. Results are entered by site staff.

Rehearse your week-24 visit in the sandbox

Build the walk test, the functional class and the worsening log, and let your site investigators try them. Free sandbox, no credit card.

Build your PAH study free

A rare disease, few centres

Specialist centres, long extensions and rollover

PAH is a rare disease treated at a limited number of expert centres, so enrolment is slow and each site matters. QR-code enrolment, site-level participant numbering and a separate site coordinator portal keep a small network organised. PII segregation means coordinators see participant names while researchers work with coded IDs. See multi-site clinical trial management for the cross-site view.

Most PAH programmes continue into an open-label extension for the same participants, often for years, and participants on placebo usually cross over. Build the extension as an epoch of the same study rather than a new database so the baseline, walk-test history and audit trail stay continuous. The long-term extension study page covers the design.

Because many sponsors are small rare-disease companies, see also the page on rare disease clinical trial software for the foundation-led side. If a registry runs alongside the trial, registry studies explains how the data models differ.

Build sequence

From PAH protocol to a live study

  1. 1

    Draft visits and forms

    Upload the protocol (PDF, DOCX or DOC) and let the AI study builder propose the schedule and forms for review. Nothing is saved until a person approves it.

  2. 2

    Define the endpoint components

    Write the clinical-worsening definition into the form options exactly as the protocol states it.

  3. 3

    Add windows and range checks

    Allowed windows around week 12 and week 24, plausible distance bands, SpO₂ and NT-proBNP ranges.

  4. 4

    Build the haemodynamics form

    Add the catheterisation fields and any derived resistance calculation, and have the cardiologist check the result against a worked example.

  5. 5

    Test in the sandbox

    Run practice participants through screening, week 24 and an extension visit, then read the audit trail of a corrected walk distance.

  6. 6

    Approve and go live

    Approved forms lock for live use. Real participants start the paid live phase.

Before first participant

PAH study readiness checklist

Walk test procedure standardised

Corridor length, encouragement script, oxygen rule and tester recorded on the form.

Worsening definition locked

Components and the first-event rule identical in protocol, form and analysis plan.

Haemodynamic formulas verified

Derived values checked against a worked example before go-live.

Visit windows set

Windows match the protocol so late tests are visible.

Extension plan

Epochs and consent for rollover agreed before the double-blind phase closes.

Export tested

CSV or Excel with the data dictionary opened in the statistics package.

FAQ

Questions teams ask before they switch

Something not covered here? Ask us directly.

Can Capture record 6-minute walk distance and change from baseline?

Yes. The walk test is a site eCRF form with distance, Borg score, oxygen and tester fields, and a change from baseline can be shown as a calculated field. A range edit check can flag implausible distances.

How do I capture clinical worsening events?

As a repeating event log with type, date and source. Each row has its own audit trail, so the first-event date for a time-to-event analysis is traceable.

Does Capture calculate pulmonary vascular resistance?

Capture supports calculated fields, and a study team can define one. It does not ship a PAH-specific resistance formula, so confirm the formula and inputs with your cardiologist and test it with a worked example.

Can it connect to echo or catheter lab systems?

No integration is claimed. Site staff enter results from the report, and source data verification can be set per field.

Can the same study continue into an open-label extension?

Yes. Build the extension as an epoch so baseline data, the walk-test history and the audit trail continue without a second database.

Is Capture suitable for Phase 3 PAH programmes?

Yes. Capture is suitable for Phase 1, 2 and 3 studies, and multi-site work uses site-level numbering, a site coordinator portal and by-site exports.

How much does it cost?

The sandbox is free with every feature, no credit card and no time limit. You pay only once you go live with real participants. Pricing is not published on the site, so ask for terms for your study.

Start building your PAH study free

Free sandbox with every feature. No credit card, and you pay only when you go live.

Build your PAH study free